Description
Founded in 1969, Eight Roads is a venture capital arm of Fidelity International based in London, United Kingdom. The firm seeks to invest in the healthcare and technology sectors.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
NOCD | 31-Jan-2023 | Later Stage VC | 0000 | Practice Management (Healthcare) | Generating Revenue | |
000000 00000000000 | 29-Jan-2023 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 0000 000000 00.0 |
00000000 | 18-Jan-2023 | 00000 00000 | 0000 | Storage (IT) | Generating Revenue | 00000 00000000 |
0000 (000000000000 | 15-Jan-2023 | 0000 00000 | 00.000 | Business/Productivity Software | Generating Revenue | |
0000000 00 | 19-Dec-2022 | 00000 00000 | 000.00 | Business/Productivity Software | Generating Revenue | 000000 00000 |
00000000000 000 | 15-Dec-2022 | 0000 00000 | 0000 | Drug Delivery | Startup | 000 000 |
000 0000000000 | 06-Dec-2022 | 00000 00000 | 0000 | Other Devices and Supplies | Pre-Clinical Trials | |
0000 | 05-Dec-2022 | 00000 00000 | 0000 | Agricultural Chemicals | Generating Revenue | |
Ruiyun Cold Chain | 22-Nov-2022 | Early Stage VC | 000.00 | Logistics | Generating Revenue | |
Zhuhai Meihua Medical Technology | 17-Nov-2022 | Later Stage VC | 000.00 | Diagnostic Equipment | Generating Revenue | 000 000 00.0 |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Medbanks | 23-Dec-2022 | IPO | 000.00 |
00000 00000000 | 10-Dec-2022 | 0000000000: 000000 | |
000000 | 22-Nov-2022 | 000000000000000000 | |
00000 | 27-Oct-2022 | 0000000000 | |
00000000 | 24-Aug-2022 | 000000000000000000 | |
0000000 | 30-Jun-2022 | 000000000000000000 | 000.00 |
000000000000 00000 | 01-May-2022 | 000000000 00000000 | |
00000 | 31-Mar-2022 | 000000000000000000 | 00000 |
8fit | 02-Feb-2022 | Merger/Acquisition | |
Optimus Ride | 12-Jan-2022 | Merger/Acquisition |
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Kristina Isherwood | Chief Financial Officer | 0 | 0 | 0 | London, United Kingdom |
Jarlon Tsang JD | Managing Partner & Head of China | 0 | 0 | Hong Kong, Hong Kong | |
David Milstein | Managing Partner & Head of Japan | 00 | 0 | 0 | Tokyo, Japan |
Daniel Auerbach | Senior Managing Partner & Head of Global Ventures | 00 | 0 | 0 | Hong Kong, Hong Kong |
Davor Hebel | Managing Partner, Head of Europe | 00 | 0 | 0 | London, United Kingdom |
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
F-Prime Capital | 60 | 0 | 00 |
![]() |
![]() |
Sequoia Capital China | 00 | 0 |
![]() |
![]() |
|
SMBC Venture Capital | 0 | 0 |
![]() |
![]() |
|
Fidelity International Strategic Ventures | 0 | 0 | 0 |
![]() |
![]() |
Accel | 0 | 0 | 0 |
![]() |
![]() |